NCT00150839View on ClinicalTrials.gov

Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Depressive Disorder, Major
Interventions
DRUG

Mirtazapine

Patients receive mirtazapine 45mg and placebo.

DRUG

Venlafaxine

Patients receive mirtazapine 45mg and venlafaxine 300mg.

Trial Locations (1)

91054

Department of Psychiatry and Psychotherapy, University Erlangen-Nuremberg, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT00150839 - Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy | Biotech Hunter | Biotech Hunter